Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Breakthrough Clinical Results Teva Pharmaceuticals announced the FDA approval and US launch of its generic version of Saxenda (liraglutide injection), the first generic glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight loss
The eligibility study reported by Fierce Healthcare underscores how large this overlap is: the semaglutide-eligible population it identified included tens of millions of adults covered by Medicare and Medicaid, many of whom qualify through diabetes or cardiovascular indications rather than weight criteria alone
Whatever stage retatrutide reaches in development, a dual-action treatment that is licensed and available in the UK today is Mounjaro (tirzepatide) injections, which a registered prescriber can assess for suitability
At 20 mg/mL, the difference between 12.5 units and 25 units is the difference between 2.5 mg and 5.0 mg
JAMA 12 , 22112223 (2017)
If you're not satisfied with your order and wish to return one or more items, please contact our Customer Care Team at [email protected] within 14 days of delivery
US$ 21.38
US$ 24.19
US$ 26.04
US$ 26.39
US$ 20.34
US$ 20.71
